Share this post on:

Product Name :
zabedosertib

Search keywords :
Zabedosertib

drugId :
null

Target Vo:
Interleukin-1 receptor-associated kinase 4

Target Vo Short Name :
IRAK4

Moa_Name:
Interleukin-1 receptor-associated kinase 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bayer AG

Active Company_Name :
Bayer AG

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:
Pelvic Inflammatory Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p53 Antibody
AKT1/AKT2/AKT3 Antibody (YA635)
ATP citrate lyase Antibody: ATP citrate lyase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 121 kDa, targeting to ATP citrate lyase. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related